APA

Saied A., Licata L., Burga R. A., Thorn M., McCormack E., Stainken B. F., Assanah E. O., Khare P. D., Davies R., Espat N. J., Junghans R. P. & Katz S. C. (20150715). Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases. : Cancer gene therapy.

Chicago

Saied A, Licata L, Burga R A, Thorn M, McCormack E, Stainken B F, Assanah E O, Khare P D, Davies R, Espat N J, Junghans R P and Katz S C. 20150715. Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases. : Cancer gene therapy.

Harvard

Saied A., Licata L., Burga R. A., Thorn M., McCormack E., Stainken B. F., Assanah E. O., Khare P. D., Davies R., Espat N. J., Junghans R. P. and Katz S. C. (20150715). Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases. : Cancer gene therapy.

MLA

Saied A, Licata L, Burga R A, Thorn M, McCormack E, Stainken B F, Assanah E O, Khare P D, Davies R, Espat N J, Junghans R P and Katz S C. Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases. : Cancer gene therapy. 20150715.